Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It's 0.07 pence rather than 7p I'm afraid. Hardly a bonanza, but better than a poke in the eye with a sharp stick, and hopefully a step towards better things.
Hi All - am very new at this, but been with APH for years and it's all coming good in the new year with maiden dividend. Can anyone tell me if this is £0.07p i.e Seven Pence , or 0.07p i.e Seven Hundredths of Once Pence per share. Please help and apologies for being green as I am cabbage looking. Swinny
http://sharecrazy.com/beta/Tips/2514/alliance-pharma-reiterate-buy-at-195p
Same here, in at 5p. Unfortunately took my original investment out at 14p and just let the profit run. Great performance and divi's to come too
I have to say I have been in this share since January. Bought at just over 4p. Have been delighted with the company's progress. Was a bit thrown when Myosotis, for whom I have great respect, bowed out on the basis that the recent acquisitions were not likely to be winners. His opinion was based on practical experience in the industry and accordingly had, for me, considerable weight. On the other hand I noted that Nigel Wray, a man who clearly knows a good share when he sees one, increased his holding by some 4,000,000 shares. I decided, with no disrespect to Myo, to stick with it and I am glad I did.
Yes, I head the interview: All good news. Discussed results, share price etc. Outlined trading strategy and target market in a sensible and modest manner. Got to be v.positive for the next year.
Brilliant results yet again from APH. I understand the Chairman was on the Today programme on radio 4 this morning being congratulated on being the little star of the AIM market. Cannot be bad publicity for the share.
Hi any doctors out there still writing scrips for Timodine and Buccastem or do you recommend newer products?
Not all the "sells" are "sells" as my BUY is showing as a Sell this morning. MM's trying to panic people into selling so they can gather in some stock in readiness for the results in just over a weeks time ?
Damn you, I'm only in at 5.1p. @I can't believe how well this has done. Nothing spectacular day by day, but in the long term fantastic returns. Does anyone have any idea what the divi is likely to be?
congrats! im in since the days of 5p also! onwards an upwards i hope.ATB OP
Happy Days! Still in here from 5p! onwards to 20p now, no rush
reacting quite well to the news!
-The consideration for the Acquisition of GBP7.5 million is to be satisfied as to GBP3.8 million in cash and as to GBP3.7 million by way of a vendor share placing by the Company. -The Company has conditionally raised a further GBP0.2 million by way of a cash placing to be applied by the Company to settle the costs and expenses in relation to the Vendor Placing and the Acquisition. -In total, 31,200,000 new ordinary shares of 1 pence each in the capital of Alliance have been placed with certain existing and new U.K. investors by Numis Securities Limited at a placing price of 12.5 pence per share. -To fund the cash element of the Acquisition, Lloyds Banking Group is providing an additional GBP2 million term loan and increasing the existing GBP3 million working capital facility to GBP5 million. -In a trading update issued on July 7, Alliance announced that the Group's profit before tax for the six months ended June 30, was expected to be not less than GBP2.7 million. -Operating profit for the same period was approximately GBP4.1 million, up 46% on the same period in 2008, and the net bank debt at June 30 was GBP23.1 million, a reduction of GBP2.1 million since Dec. 31, 2008. -The Company is proposing to declare a maiden interim dividend in September 2009, to be paid in January 2010.
Alliance Pharma Buys Worldwide Rights To Brands For GBP7.5 Million LONDON -(Dow Jones)- Alliance Pharma PLC (APH.LN), a speciality pharmaceutical company, said Tuesday that its wholly-owned subsidiary, Alliance Pharmaceuticals Limited, or APL, has conditionally agreed to buy the worldwide rights to the Buccastem and Timodine brands from various subsidiaries of Reckitt Benckiser Group PLC (RB.LN) for a total consideration of GBP7.5 million. MAIN FACTS: -Buccastem is sold mainly on prescription as a treatment for nausea and vomiting, and for symptomatic treatment of other conditions such as vertigo. -Timodine is a broad spectrum anti-fungal and anti-bacterial skin cream used for treating inflamed and infected skin conditions in which the Candida albicans fungus is a factor. Uses of Timodine include treatment of severe nappy rash, eczema and other dermatoses. -In the year ended Dec. 31, 2008, total sales of the two brands were GBP2.6 million (of which GBP1.6 million were sales of Buccastem and GBP1.0 million were sales of Timodine ) and the total gross margin of the two brands was GBP2.2 million. -The majority of the sales of both brands were within the United Kingdom.The Acquisition is expected to be significantly earnings enhancing in the first full year of ownership by Alliance. contd...
i have been in here a while now and have reallly only seen rises. I cant see this news changing it. I like that they are expanding and hopefully we should see this rise a bit more and faster than i had anticipated. I was already adding to my position in the lead up to the 9th where i can see us touching 19p, perhaps now we may touch/break 20p? However i do have 2 big concerns. firstly the dilution and the 12p placing price and secondly the level of debt they are going to which was already pretty big. I have full confidence in this company though from what was originally a day trade which turned into a long term hold, i would not be too disapointed to see the postponement of a dividend in place of reducing the debt more. Of course in todays market its anyones guess... maybe we see a dive down to 12p!? hopefully not but if so i would certainly add more. ATB tmrw follks.. and heres hoping to 18p! OP
Looks good to me. I think w could see a good rise up to 9th September when they announce the maiden divi. What does anyone else think?
Anyone see a rise in these tomorrow on the back of this?
http://investegate.co.uk/Article.aspx?id=200908181835496580X
Sell off probably because the share is no longer motoring ahead at the speed it has been doing over the past 3 months. Slow and steady will be fine by me. September 9th announcement that they have made more money in the first 6 months of this year than they did in the whole of last year is good also. Then there is the prospect of a dividend being paid next year so management have stated. IMO this company has more going for it than a lot of others at the moment.
Why has there been such a huge sell off here. Is there something I do not know?
since 6p so in nice profit. Was wondering what ppls target prices are for when dividends commence. Is 25p realistic?
Is anyone likely to able to attend this presentation? Its a bit too far for me to travel for an hour or so but would be most interested to hear what APH and Sync have to say. If anyone is going they might like to ask if APH envisage their 'flu drug being used in the treatment of swine 'flu if a) the predicted epidemic materialises in the autumn and b) there is a shortage of the current drug of choice.
Proactive Investors One2One Forums The directors of Netplay TV Plc (AIM: NPT), Synchronica plc (AIM: SYNC) and Alliance Pharma plc (AIM: APH) will be presenting: Wednesday the 22nd July 2009 Venue : Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair, W1J 5EB The presentations will start at 6:00pm and finish at approx 7:30pm. After the presentations are complete the directors will also be available to take questions during a free canapé and wine reception. Details on the presenting companies can be found below. Register Here : http://www.proactiveinvestors.co.uk/eventregistration.php These are really good events set in a wonderful location, and are an excellent chance to meet the CEo's of these companies and have an informal chat over free wine and canapé after the formal presentations are complete. The evenings have a good balance of city professionals, and private investors. If you have any problems registering or queries please email : action@proactiveinvestors.com Nearest tube stations are Green Park (5 minutes walk) and Bond Street (7 mins)